ConductScience.org, home

Paper39159263

The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation.

Borrego B and 5 others. PLoS Negl Trop Dis, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation. Papers, record 39159263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39159263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation.
PubMed
Journal
PLoS Negl Trop Dis
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.53, provisional
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Borrego BBelénhttps://orcid.org/0000-0002-0801-9166
2Alonso CCelia
3Moreno SSandra
4de la Losa NNuria
5Sánchez-Cordón PJPedro José
6Brun AAlejandro

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Rift Valley FeverMajor topic
Vaccines, AttenuatedMajor topic
Rift Valley fever virusMajor topic
Viral VaccinesMajor topic
Administration, IntranasalMajor topic
Animals
Mice
Female
Vaccination
Antibodies, Viral

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AGL2017-83326-RMinisterio de Ciencia e InnovaciónPubMed
10.13039/501100011033European Union Next Generation EU/PRTRPubMed

Source PubMed

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133633696A Hyper-Attenuated Variant of Rift Valley Fever Virus Generated by a Mutagenic Drug (Favipiravir) Unveils Potential Virulence Markers.Front Microbiol2020https://conductscience.org/library/papers/33633696PubMed
236173701Advances in Understanding Neuropathogenesis of Rift Valley Fever Virus.Annu Rev Virol2022https://conductscience.org/library/papers/36173701PubMed
326718688Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.Vaccine2016https://conductscience.org/library/papers/26718688PubMed
432059491MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses.Vaccines (Basel)2020https://conductscience.org/library/papers/32059491PubMed
57485695Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment.Am J Trop Med Hyg1995https://conductscience.org/library/papers/7485695PubMed
64045430Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development.J Gen Virol1985https://conductscience.org/library/papers/4045430PubMed
736307416Immune correlates of protection following Rift Valley fever virus vaccination.NPJ Vaccines2022https://conductscience.org/library/papers/36307416PubMed
819335238Rift Valley fever virus.J Am Vet Med Assoc2009https://conductscience.org/library/papers/19335238PubMed
929511140Type I interferon receptor knockout mice as models for infection of highly pathogenic viruses with outbreak potential.Zool Res2018https://conductscience.org/library/papers/29511140PubMed
1021188836Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.Vet Res2010https://conductscience.org/library/papers/21188836PubMed
1120682902Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007.Am J Trop Med Hyg2010https://conductscience.org/library/papers/20682902PubMed
1225764399Factors associated with severe human Rift Valley fever in Sangailu, Garissa County, Kenya.PLoS Negl Trop Dis2015https://conductscience.org/library/papers/25764399PubMed
1312092782Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep.Onderstepoort J Vet Res2002https://conductscience.org/library/papers/12092782PubMed
1433805122The Change P82L in the Rift Valley Fever Virus NSs Protein Confers Attenuation in Mice.Viruses2021https://conductscience.org/library/papers/33805122PubMed
151774469Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey.J Interferon Res1991https://conductscience.org/library/papers/1774469PubMed
1627771072Mouse model for the Rift Valley fever virus MP12 strain infection.Vet Microbiol2016https://conductscience.org/library/papers/27771072PubMed
1736122681Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease.Am J Trop Med Hyg2022https://conductscience.org/library/papers/36122681PubMed
1838257787Safety and Efficacy upon Infection in Sheep with Rift Valley Fever Virus ZH548-rA2, a Triple Mutant Rescued Virus.Viruses2024https://conductscience.org/library/papers/38257787PubMed
1936992291Perspectives of Next-Generation Live-Attenuated Rift Valley Fever Vaccines for Animal and Human Use.Vaccines (Basel)2023https://conductscience.org/library/papers/36992291PubMed
2023593523Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development.PLoS Negl Trop Dis2013https://conductscience.org/library/papers/23593523PubMed

See all 49 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42728254Dual-antigen AdV5 vaccines against Crimean-Congo hemorrhagic fever virus induce superior humoral and Th1-biased cellular immunity.Sci Rep2026https://conductscience.org/library/papers/42728254PubMed
41481750Attenuated viral strains of priority pathogens for potential use in controlled human infection model studies: A scoping review.PLoS Negl Trop Dis2026https://conductscience.org/library/papers/41481750PubMed
40883324The 40Fp8 vaccine strain is safe and protects pregnant ewes from a virulent RVFV challenge.NPJ Vaccines2025https://conductscience.org/library/papers/40883324PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNAR13454PubTator's text mininghttps://conductscience.org/library/genes/3454

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39159263

GET https://conductscience.org/api/papers/v1/39159263/references?page=2